Palatin Technologies
PTN
#10927
Rank
$11.16 M
Marketcap
$6.27
Share price
9.81%
Change (1 day)
-50.75%
Change (1 year)

Palatin Technologies (PTN) - Total assets

Total assets on the balance sheet as of June 2026 : $8.52 Million USD

According to Palatin Technologies's latest financial reports the company's total assets are $8.52 Million USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Palatin Technologies - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-06-30$17.93 M-50.27%
2022-06-30$36.07 M-46.4%
2021-06-30$67.29 M-20.88%
2020-06-30$85.05 M-18.79%
2019-06-30$0.10 B168.44%
2018-06-30$39.01 M-31.35%
2017-06-30$56.83 M423.42%
2016-06-30$10.85 M-63.16%
2015-06-30$29.47 M134.69%
2014-06-30$12.55 M-49.91%
2013-06-30$25.07 M366.02%
2012-06-30$5.38 M-74.59%
2011-06-30$21.17 M70.9%
2010-06-30$12.38 M-6.14%
2009-06-30$13.19 M-30.98%
2008-06-30$19.12 M-55.3%
2007-06-30$42.78 M6.83%
2006-06-30$40.04 M13.88%
2005-06-30$35.16 M26.5%
2004-06-30$27.8 M22.35%
2003-06-30$22.72 M83.85%
2002-06-30$12.35 M-13.24%
2001-06-30$14.24 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
$197.42 B 2,316,048.22%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$115.83 B 1,358,828.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$5.35 B 62,771.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
$40.43 M 374.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$2.18 B 25,544.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
$1.49 B 17,428.58%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
$5.99 M-29.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
$0.57 B 6,656.27%๐Ÿ‡บ๐Ÿ‡ธ USA